Andrew P Ambrosy1,2, Jerry H Gurwitz3,4, Grace H Tabada2, Andrew Artz5, Stanley Schrier6, Sunil V Rao7,8, Huiman X Barnhart8, Kristi Reynolds9, David H Smith10, Pamela N Peterson11,12,13, Sue Hee Sung2, Harvey Jay Cohen14, Alan S Go2,15,16. 1. Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA. 2. Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, USA. 3. Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, MA, USA. 4. Meyers Primary Care Institute, Worcester, MA, USA. 5. Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. 6. Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA. 7. Division of Cardiology, Duke University Medical Center, Durham, NC, USA. 8. Duke Clinical Research Institute, Duke University Medical School, Durham, NC, USA. 9. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 10. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. 11. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA. 12. Denver Health Medical Center, Denver, CO, USA. 13. University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 14. Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA. 15. Department of Epidemiology, Biostatistics and Medicine, University of California at San Francisco, San Francisco, CA, USA. 16. Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Abstract
AIMS: Limited data exist on the epidemiology, evaluation, and prognosis of otherwise unexplained anaemia of the elderly in heart failure (HF). Thus, we aimed to determine the incidence of anaemia, to characterize diagnostic testing patterns for potentially reversible causes of anaemia, and to evaluate the independent association between incident anaemia and long-term morbidity and mortality. METHODS AND RESULTS: Within the Cardiovascular Research Network (CVRN), we identified adults age ≥65 years with diagnosed HF between 2005 and 2012 and no anaemia at entry. Incident anaemia was defined using World Health Organization (WHO) haemoglobin thresholds (<13.0 g/dL in men; <12.0 g/dL in women). All-cause death and hospitalizations for HF and any cause were identified from electronic health records. Among 38 826 older HF patients, 22 163 (57.1%) developed incident anaemia over a median (interquartile range) follow-up of 2.9 (1.2-5.6) years. The crude rate [95% confidence interval (CI)] per 100 person-years of incident anaemia was 26.4 (95% CI 26.0-26.7) and was higher for preserved ejection fraction (EF) [29.2 (95% CI 28.6-29.8)] compared with borderline EF [26.5 (95% CI 25.4-27.7)] or reduced EF [26.6 (95% CI 25.8-27.4)]. Iron indices, vitamin B12 level, and thyroid testing were performed in 20.9%, 14.9%, and 40.2% of patients, respectively. Reduced iron stores, vitamin B12 deficiency, and/or hypothyroidism were present in 29.7%, 3.2%, and 18.6% of tested patients, respectively. In multivariable analyses, incident anaemia was associated with excess mortality [hazard ratio (HR) 2.14, 95% CI 2.07-2.22] as well as hospitalization for HF (HR 1.80, 95% CI 1.72-1.88) and any cause (HR 1.77, 95% CI 1.72-1.83). CONCLUSION: Among older adults with HF, incident anaemia is common and independently associated with substantially increased risks of morbidity and mortality. Additional research is necessary to clarify the value of routine evaluation and treatment of potentially reversible causes of anaemia. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Limited data exist on the epidemiology, evaluation, and prognosis of otherwise unexplained anaemia of the elderly in heart failure (HF). Thus, we aimed to determine the incidence of anaemia, to characterize diagnostic testing patterns for potentially reversible causes of anaemia, and to evaluate the independent association between incident anaemia and long-term morbidity and mortality. METHODS AND RESULTS: Within the Cardiovascular Research Network (CVRN), we identified adults age ≥65 years with diagnosed HF between 2005 and 2012 and no anaemia at entry. Incident anaemia was defined using World Health Organization (WHO) haemoglobin thresholds (<13.0 g/dL in men; <12.0 g/dL in women). All-cause death and hospitalizations for HF and any cause were identified from electronic health records. Among 38 826 older HF patients, 22 163 (57.1%) developed incident anaemia over a median (interquartile range) follow-up of 2.9 (1.2-5.6) years. The crude rate [95% confidence interval (CI)] per 100 person-years of incident anaemia was 26.4 (95% CI 26.0-26.7) and was higher for preserved ejection fraction (EF) [29.2 (95% CI 28.6-29.8)] compared with borderline EF [26.5 (95% CI 25.4-27.7)] or reduced EF [26.6 (95% CI 25.8-27.4)]. Iron indices, vitamin B12 level, and thyroid testing were performed in 20.9%, 14.9%, and 40.2% of patients, respectively. Reduced iron stores, vitamin B12 deficiency, and/or hypothyroidism were present in 29.7%, 3.2%, and 18.6% of tested patients, respectively. In multivariable analyses, incident anaemia was associated with excess mortality [hazard ratio (HR) 2.14, 95% CI 2.07-2.22] as well as hospitalization for HF (HR 1.80, 95% CI 1.72-1.88) and any cause (HR 1.77, 95% CI 1.72-1.83). CONCLUSION: Among older adults with HF, incident anaemia is common and independently associated with substantially increased risks of morbidity and mortality. Additional research is necessary to clarify the value of routine evaluation and treatment of potentially reversible causes of anaemia. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Paul R Kalra; Timothy Collier; Martin R Cowie; Kevin F Fox; David A Wood; Philip A Poole-Wilson; Andrew J S Coats; George C Sutton Journal: Lancet Date: 2003-07-19 Impact factor: 79.321
Authors: W H Wilson Tang; Wilson Tong; Anil Jain; Gary S Francis; C Martin Harris; James B Young Journal: J Am Coll Cardiol Date: 2008-02-05 Impact factor: 24.094
Authors: Jack M Guralnik; Richard S Eisenstaedt; Luigi Ferrucci; Harvey G Klein; Richard C Woodman Journal: Blood Date: 2004-07-06 Impact factor: 22.113
Authors: Alan S Go; David J Magid; Barbara Wells; Sue Hee Sung; Andrea E Cassidy-Bushrow; Robert T Greenlee; Robert D Langer; Tracy A Lieu; Karen L Margolis; Frederick A Masoudi; Catherine J McNeal; Glen H Murata; Katherine M Newton; Rachel Novotny; Kristi Reynolds; Douglas W Roblin; David H Smith; Suma Vupputuri; Robert E White; Jean Olson; John S Rumsfeld; Jerry H Gurwitz Journal: Circ Cardiovasc Qual Outcomes Date: 2008-11
Authors: Ewa A Jankowska; Stephan von Haehling; Stefan D Anker; Iain C Macdougall; Piotr Ponikowski Journal: Eur Heart J Date: 2012-10-25 Impact factor: 29.983
Authors: Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker Journal: Eur Heart J Date: 2014-08-31 Impact factor: 29.983